Press releases
* (R) = Regulatory press releases
Apr 27, 2022
(R) Cantargia to present new clinical data on lead IL1RAP antibody nadunolimab over three sessions at ASCO 2022
Mar 10, 2022
(R) Correction: Cantargia strengthens executive management in preparation for late-stage clinical development
Mar 10, 2022
Cantargia strengthens executive management in preparation for late-stage clinical development
Feb 24, 2022